REGENERON PHARMACEUTICALS, INC.(REGN)内部人交易:高管与董事近期交易
过去 18 个月,共有 19 位内部人为 REGENERON PHARMACEUTICALS, INC.(REGN)报告了 247 笔 Form 4 交易(最近一笔 2026-11-18)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-18 | McCourt Marion | EVP Commercial | 卖出 | 21 | $20,258 |
| 2026-11-18 | MURPHY ANDREW J | Co-Chief Scientific Officer | 卖出 | 313 | $298,743 |
| 2026-11-18 | MURPHY ANDREW J | Co-Chief Scientific Officer | 买入 | 17,000 | $6.5M |
| 2026-11-18 | SING GEORGE L | 董事 | 卖出 | 176 | $168,425 |
| 2026-11-18 | McCourt Marion | EVP Commercial | 卖出 | 59 | $56,313 |
| 2026-11-18 | MURPHY ANDREW J | Co-Chief Scientific Officer | 卖出 | 11,989 | $11.5M |
| 2026-11-18 | SING GEORGE L | 董事 | 卖出 | 359 | $343,739 |
| 2026-11-18 | McCourt Marion | EVP Commercial | 卖出 | 44 | $41,923 |
| 2026-11-18 | MURPHY ANDREW J | Co-Chief Scientific Officer | 卖出 | 93 | $88,321 |
| 2026-11-18 | SING GEORGE L | 董事 | 卖出 | 465 | $445,521 |
| 2026-11-18 | McCourt Marion | EVP Commercial | 卖出 | 22 | $21,032 |
| 2026-11-18 | MURPHY ANDREW J | Co-Chief Scientific Officer | 卖出 | 74 | $70,345 |
| 2026-11-18 | McCourt Marion | EVP Commercial | 卖出 | 44 | $42,173 |
| 2026-11-18 | MURPHY ANDREW J | Co-Chief Scientific Officer | 卖出 | 298 | $283,622 |
| 2026-11-18 | McCourt Marion | EVP Commercial | 卖出 | 66 | $63,324 |
| 2026-11-18 | MURPHY ANDREW J | Co-Chief Scientific Officer | 卖出 | 220 | $209,605 |
| 2026-11-18 | McCourt Marion | EVP Commercial | 卖出 | 49 | $47,055 |
| 2026-11-18 | MURPHY ANDREW J | Co-Chief Scientific Officer | 卖出 | 671 | $639,926 |
| 2026-11-18 | McCourt Marion | EVP Commercial | 卖出 | 59 | $56,720 |
| 2026-11-18 | SING GEORGE L | 董事 | 卖出 | 1,000 | $960,260 |
| 2026-11-18 | McCourt Marion | EVP Commercial | 卖出 | 41 | $39,460 |
| 2026-11-18 | MURPHY ANDREW J | Co-Chief Scientific Officer | 卖出 | 313 | $299,065 |
| 2026-11-18 | McCourt Marion | EVP Commercial | 卖出 | 42 | $40,475 |
| 2026-11-18 | MURPHY ANDREW J | Co-Chief Scientific Officer | 卖出 | 346 | $331,018 |
| 2026-11-18 | McCourt Marion | EVP Commercial | 卖出 | 30 | $28,665 |
来源:SEC Form 4 申报文件 · 截至 2026-11-18